The irreplaceable image. Thalidomide in refractory myeloma patients: early changes in bone marrow cellularity.
Zappasodi
P
P
Institute of Hematology, University of Pavia, Istituto Scientifico Policlinico San Matteo, Pavia, Italy.
Lorenzi
A
A
Corso
A
A
D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D013792:Thalidomide / Q000008:administration & dosage*
D013792:Thalidomide